141 related articles for article (PubMed ID: 37121465)
1. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
[TBL] [Abstract][Full Text] [Related]
2. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, Thereby Promoting Angiogenesis in Hepatocellular Carcinoma.
Zhang F; Wang B; Zhang W; Xu Y; Zhang C; Xue X
Curr Cancer Drug Targets; 2024 Feb; ():. PubMed ID: 38347781
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
5. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB.
Sun G; Ni K; Shen J; Liu D; Wang H
Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
Zhou Y; Yan J; Chen H; Zhou W; Yang J
Cells Tissues Organs; 2024; 213(1):55-66. PubMed ID: 36273455
[TBL] [Abstract][Full Text] [Related]
7. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
Electrophoresis; 2024 Apr; ():. PubMed ID: 38629299
[TBL] [Abstract][Full Text] [Related]
8. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
Han J; Wang Y
Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
[TBL] [Abstract][Full Text] [Related]
9. The E2F1/MELTF axis fosters the progression of lung adenocarcinoma by regulating the Notch signaling pathway.
Zhang L; Shi L
Mutat Res; 2023; 827():111837. PubMed ID: 37820570
[TBL] [Abstract][Full Text] [Related]
10.
Wang Z; Zhou L; Chen B; Li X; Zou Q; Xu W; Fang L; Wu A; Li Z; Chen Y
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107669
[TBL] [Abstract][Full Text] [Related]
11.
Jiang F; Shen Q; Zhang F; Fu J; Hu L; Wang J; Zhou H; Chen J; Wang Y
DNA Cell Biol; 2022 Jun; 41(6):631-640. PubMed ID: 35612423
[TBL] [Abstract][Full Text] [Related]
12. Let-7c-5p Represses Cisplatin Resistance of Lung Adenocarcinoma Cells by Targeting CDC25A.
Huang L; Lou K; Wang K; Liang L; Chen Y; Zhang J
Appl Biochem Biotechnol; 2023 Mar; 195(3):1644-1655. PubMed ID: 36355336
[TBL] [Abstract][Full Text] [Related]
13. EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression.
Huang M; Ding J; Wu X; Peng X; Wu G; Peng C; Zhang H; Mao C; Huang B
Mutat Res; 2022; 825():111792. PubMed ID: 35939884
[TBL] [Abstract][Full Text] [Related]
14. Ring finger protein 6 enhances chemo-resistance by transcriptionally activating proliferating cell nuclear antigen expression and attenuating DNA damage in lung adenocarcinoma.
Sun Y; Sun H; Qi Y; Pan M; An N; Leng X; Liu Y; Chen Z
Cancer Lett; 2022 May; 534():215609. PubMed ID: 35278611
[TBL] [Abstract][Full Text] [Related]
15. TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression.
Zhao J; Lan G
Pathol Res Pract; 2023 Sep; 249():154759. PubMed ID: 37586214
[TBL] [Abstract][Full Text] [Related]
16. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
17. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
[TBL] [Abstract][Full Text] [Related]
18. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
20. TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA.
Zhang S; Cao M; Yan S; Liu Y; Fan W; Cui Y; Tian F; Gu R; Cui Y; Zhan Y; Sun Y; Xing Y; Cai L; Song Y
Int J Biol Sci; 2022; 18(7):2962-2979. PubMed ID: 35541909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
